TransMedics (TMDX) Other financing activities (2018 - 2026)

TransMedics has reported Other financing activities for 9 years, with the latest figure at $1.0 million in Q2 2026.

• On a quarterly basis, Other financing activities fell 85.77% year-over-year to $1.0 million in Q2 2026; TTM through Jun 2026 was $8.1 million, a 50.56% decrease from a year earlier, with the FY2025 full-year figure at $13.7 million, down 33.95% from the prior year.
• Other financing activities was $1.0 million for Q2 2026 at TransMedics, down from $2.2 million in the prior quarter.
• The five-year high for Other financing activities was $10.6 million in Q2 2024, with the low at $203000.0 in Q1 2022.
• Average Other financing activities over 5 years is $2.7 million, with a median of $1.8 million recorded in 2025.
• The sharpest annual moves came in 2022 and 2026: Other financing activities soared 6093.33% in 2022, then plunged 85.77% in 2026.
• Over 5 years, Other financing activities stood at $2.8 million in 2022, then slumped by 66.85% to $924000.0 in 2023, then gained by 28.35% to $1.2 million in 2024, then jumped by 161.3% to $3.1 million in 2025, then slumped by 67.44% to $1.0 million in 2026.
• The last three Other financing activities figures came in at $1.0 million (Q2 2026), $2.2 million (Q1 2026), and $3.1 million (Q4 2025), per Business Quant data.